CRYO-CELL INTERNATIONAL, INC. (OTCMKTS:CCEL) Files An 8-K Entry into a Material Definitive AgreementItem 1.01.
See Item 1.01 above, which is incorporated herein by reference.
| Item 1.01. | Financial Statements and Exhibits. |
(d) Exhibits.
CRYO CELL INTERNATIONAL INC ExhibitEX-2.1 2 d587398dex21.htm EX-2.1 EX-2.1 Exhibit 2.1 Execution Copy ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this “Agreement”),…To view the full exhibit click here
About CRYO-CELL INTERNATIONAL, INC. (OTCMKTS:CCEL)
Cryo-Cell International, Inc. is engaged in cellular processing and cryogenic storage. The Company’s segments include cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacture of Prepacyte CB units, the processing technology used to process umbilical cord blood stem cells. The Company, in combination with its global affiliates, stores over 300,000 cord blood and cord tissue specimens around the world. The specimens are stored in commercially available cryogenic storage units at the facility in Oldsmar, Florida. The Company offers the cord tissue service in combination with the umbilical cord blood service. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals.
